Glaxo Settles Almost 25,000 Avandia Cases Under Mediation

GlaxoSmithKline Plc settled almost 25,000 cases over its Avandia diabetes drug in mediation as multidistrict litigation begins to wind down, lawyers told a federal judge in Philadelphia.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.